Taken together, these data strongly suggest that loss of Plexin-B1/Plexin-B2 could represent a mechanistic basis for the loss of contact inhibition, a hallmark of cancer that has remained poorly understood on a molecular level61,62. This evidence concerns the gene PLXNB2 and cancer.